• TRADE NAME: Genvoya (Gilead)
• INDICATIONS: HIV-1 infection
  
• CLASS: Antiretroviral, CYP3A inhibitor (cobicistat), Hepatitis B virus necleoside analog reverse transcriptase inhibitor (tenofovir alafenamide), Integrase strand transfer inhibitor (elvitegravir), Nucleoside analog reverse transcriptase inhibitor (emtricitabine)
• HALF-LIFE: 3.5 hours (cobicistat); 13 hours (elvitegravir); 10 hours (emtricitabine); <1 hour (tenofovir alafenamide)

FDA APPROVAL DATE: 11/05/2015 (Genvoya)

Acyclovir, Aminoglycosides, Amiodarone, Amitriptyline, Amlodipine, Antacids, Antiarrhythmics, Atorvastatin, Benzodiazepines, Bepridil, Beta blockers, Bosentan, Buprenorphine, Bupropion, Buspirone, Calcium channel blockers, Cidofovir, Clarithromycin, Clorazepate, Colchicine, Desipramine, Dexamethasone, Diazepam, Digoxin, Diltiazem, Disopyramide, Drugs affecting renal function, Estazolam, Ethosuximide, Felodipine, Flecainide, Flurazepam, Fluticasone Furoate, Fluticasone Propionate, Ganciclovir, Gentamicin, Hormonal contraceptives, Imipramine, Immunosuppressants, Itraconazole, Ketoconazole, Lidocaine, Lorazepam, Metoprolol, Mexiletine, Midazolam, Naloxone, Neuroleptics, Nicardipine, Nifedipine, Nortriptyline, Oxcarbazepine, Paroxetine Hydrochloride, Perphenazine, Propafenone, Quinidine, Rifabutin, Rifapentine, Risperidone, Salmeterol, Sildenafil, SSRIs, Tadalafil, Telithromycin, Thioridazine, Timolol, Trazodone, Tricyclic antidepressants, Valacyclovir, Valganciclovir, Vardenafil, Verapamil, Voriconazole, Warfarin, Zolpidem

PREGNANCY CATEGORY: B